BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2894653)

  • 21. Immunosuppression and beta-blockade in heart failure.
    Lee HR; O'Connell JB; Mason JW
    Cardiol Clin; 1989 Feb; 7(1):171-81. PubMed ID: 2565162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathies.
    Waagstein F
    Heart Vessels Suppl; 1991; 6():18-28. PubMed ID: 1687923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical treatment for cardiomyopathies].
    Suwa M
    Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology and current therapy of congestive heart failure due to idiopathic cardiomyopathy].
    Kambayashi M; Kumada T
    Nihon Rinsho; 1993 May; 51(5):1328-32. PubMed ID: 8101239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of beta-blockers in left ventricular dysfunction and heart failure.
    Hjalmarson A; Kneider M; Waagstein F
    Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled trials with beta blockers in heart failure: metoprolol as the prototype.
    Fowler MB
    Am J Cardiol; 1993 Mar; 71(9):45C-53C. PubMed ID: 8096675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-blocker therapy for chronic heart failure in patients with dilated cardiomyopathy].
    Hori M; Kagiya T; Sato H; Kitabatake A
    Kokyu To Junkan; 1990 Dec; 38(12):1203-9. PubMed ID: 1981100
    [No Abstract]   [Full Text] [Related]  

  • 28. [Case of dilated cardiomyopathy with marked improvement of the cardiac function with beta block treatment and exacerbation with the interruption of the treatment].
    Shimizu K; Morimoto S; Yamada K; Hiramitsu S; Uemura A; Kubo N; Kimura K; Kato Y; Kato S; Hishida H
    Nihon Naika Gakkai Zasshi; 1997 May; 86(5):840-2. PubMed ID: 9280773
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of statin therapy on mortality in patients with non-ischemic dilated cardiomyopathy].
    Li X; Liu XP; Liu XH; Du X; Kang JP; Lü Q; Wang HY; Xu X; Liang C; Yan Q; Lei T; Geng LL; Liu BQ; Ma CS
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):1974-7. PubMed ID: 20979862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-1-selectivity is not essential to achieve therapeutic efficacy with beta-blockade therapy for idiopathic dilated cardiomyopathy.
    Yoshikawa T; Handa S; Akaishi M; Mitamura H; Ogawa S
    Cardiology; 1995; 86(3):217-23. PubMed ID: 7614494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint.
    Yamada T; Fukunami M; Ohmori M; Iwakura K; Kumagai K; Kondoh N; Minamino T; Tsujimura E; Nagareda T; Kotoh K
    J Am Coll Cardiol; 1993 Mar; 21(3):628-33. PubMed ID: 8094721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic beta-blocking agents in congestive heart failure due to idiopathic dilated cardiomyopathy.
    Waagstein F
    Eur Heart J; 1995 Dec; 16 Suppl O():128-32. PubMed ID: 8682079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
    Freudenberger R; Kalman J; Mannino M; Buchholz-Varley C; Ocampo O; Kukin M
    Am J Cardiol; 1997 Nov; 80(10):1372-4. PubMed ID: 9388121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of cardiac insufficiency by beta-blockaders. A review of the literature and discussion].
    Hermida JS; Jarry G; Bertrand S; Guillaumont MP; Rey JL; Bernasconi P
    Ann Cardiol Angeiol (Paris); 1990 Feb; 39(2):103-7. PubMed ID: 1970467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.
    Gilbert EM; O'Connell JB; Bristow MR
    Heart Vessels Suppl; 1991; 6():29-39. PubMed ID: 1687924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure.
    Andersson B; Blomström-Lundqvist C; Hedner T; Waagstein F
    J Am Coll Cardiol; 1991 Oct; 18(4):1059-66. PubMed ID: 1680132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of metoprolol on absolute myocardial blood flow in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bennett SK; Smith MF; Gottlieb SS; Fisher ML; Bacharach SL; Dilsizian V
    Am J Cardiol; 2002 Jun; 89(12):1431-4. PubMed ID: 12062744
    [No Abstract]   [Full Text] [Related]  

  • 38. Troponin I release at rest and after exercise in patients with hypertrophic cardiomyopathy and the effect of betablockade.
    Pop GA; Cramer E; Timmermans J; Bos H; Verheugt FW
    Arch Cardiol Mex; 2006; 76(4):415-8. PubMed ID: 17315619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta blockers in cardiomyopathy: status report 2010.
    Talwar KK; Poddar P
    Indian Heart J; 2010; 62(2):123-5. PubMed ID: 21180301
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of beta blockers in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy.
    Waagstein F
    Am J Cardiol; 1997 Nov; 80(9B):45J-49J. PubMed ID: 9375950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.